瑞士诺华的地拉罗司效果好不好

Fifty-eight children with iron overload of β-thalassemia major were selected as the subjects of this study and divided into a control group and an observation group using the random number table method, with 29 cases in each group. Children in the control group were given deferoxamine treatment, and children in the observation group were given treatment for 6 months. The clinical effects, heart and liver magnetic resonance imaging (MRI) T2* examination results of the two groups of children after no treatment were compared.

Results After 6 months of treatment, there was no statistically significant difference in the total effective rate between the two groups (P>0.05). Among them, the total control rate of the observation group was 96.55%, which was higher than that of the control group 72.41%. The difference between the two groups of data was statistically significant (P<0.05); the T2* data values of the heart (39.65±13.57) ms and liver (8.37±2.84) ms of the children in the observation group were significantly higher than those of the control group (31.56±12.49) ms and liver (3.84=2.01). ) ms is high, and there is a significant difference between the two groups of data with statistical significance (t=3.398, P-0.001; t=10.085, P=0.000). Conclusion: Deferasirox has a good effect in the treatment of iron overload in β-thalassemia major. Its clinical effect is significantly higher than that of deferoxamine. It has better iron removal effect and greatly promotes the recovery of children. It deserves to be widely used and promoted.

Currently, the one most favored by patients is the one produced by Novartis in Switzerland. Novartis is a pharmaceutical and biotechnology multinational company headquartered in Basel, Switzerland. Its core businesses are in various patent medicines, consumer healthcare, generic medicines, eye care and animal health. According to Medical Companion Travel, the specification of Deferasirox from Novartis Switzerland is 400mg*30 tablets, but the price is only 420$, which is more suitable for patients for long-term use. Since the exchange rate is not static, the price will also fluctuate. For details, please consult Medical Companion Travel.

Recommended related hot articles: /newsDetail/94082.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.